Delivery Order SPE2DB20D2104-SPE2DB21FT64Q
Award Date 8/11/21
Potential Completion Date 8/12/21
Potential Value $17K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,892.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product REXULTI 0.5 MG TABLET 30S. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,965.35 firm fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,998.80 firm-fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,911.06 firm fixed-price delivery order is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,424.07 Firm Fixed Price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $14,948.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REXULTI 2 MG TABLET 30S, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and is therefore open to competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,705.82 firm-fixed-price delivery order is for the provision of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award has a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,812.86 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $17,478.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of REXULTI 1 MG TABLET 30S, a prescription medication. The contract is a firm-fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract award, valued at $26,814.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on November 22, 2023. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...